Looking back to move forward: a twenty-year audit of herpes zoster in Asia-Pacific

Chen, Liang-Kung; Arai, Hidenori; Chen, Liang-Yu; Chou, Ming-Yueh; Djauzi, Samsuridjal; Dong, Birong; Kojima, Taro; Kwon, Ki Tae; Leong, Hoe Nam; Leung, Edward M. F.; Liang, Chih-Kuang; Liu, Xiaohong; Mathai, Dilip; Pan, Jiun Yit; Peng, Li-Ning; Poblete, Eduardo Rommel S.; Poi, Philip J. H.; Reid, Stewart; Tantawichien, Terapong; Won, Chang Won

doi:10.1186/s12879-017-2198-y

BMC Infectious Diseases

Table 5 Herpes zoster complication rates in Asia-Pacific patients

From: Looking back to move forward: a twenty-year audit of herpes zoster in Asia-Pacific

Country (source)	Setting (number of patients)	Age profile (years)	Proportions with complications (%)
			Post-herpetic neuralgia (months)				Ocular	Otic	Motor	Infections		≥1 overall
			NS	≥1	≥3	≥6				Skin	LRT
Taiwan (Lin 2010) [136]	Hospitals (2.93% of 672783)	63% >40	52.5 (neurologic including PHN)				24.1	52.4		19.0	10.1	47.0
Australia (MacIntyre 2003) [102]	Hospitals (4718)	Mean 69	33.1 neurologic				16.0					58.5
Korea (Kim YM 2008) [11]	Dermatology (297)	NA	30.0				7.7	NA	1.4^a	9.8		40.7
Korea (Lee 2006) [354]	Hospital (333)	NA	15.6				6.9	0.6	0.3^a	1.5		NA
Korea (Park 2004) [26]	Dermatology (1089)	NA	7.4				3.2	0.2	0.4^a	1.8		NA
Philippines (Jara 2010) [15]	Hospital (221)	Mean 43			2.3		5.0			6.3		12.2
Thailand (Aunhachoke 2011) [30]	Hospitals/tertiary centres (180)	Mean 59			19.4		7.2
Singapore (Oh 1997) [340]	Hospital (67)	Mean 50	13.4				5.0			61.0		85.0
India (Abdul Latheef 2011) [12]	Hospital (205)	47% >40	10.2					1.0	0.5	13.6		34.6
Australia (Stein 2009) [104]	General Practice (379)^b	100% >50	15.0				16.2^c					61.3^c
Japan (Akiyama 2000) [454]	Hospital (1432)	Mean 54							0.8
India (Gopal 2010) [449]	Dermatology (100)								3.0
Korea (Son 2011) [448]	Hospital (711)								2.1
Korea (Min 2007) [418]	Dermatology (1787)	Mean 62						4.7
Korea (Kim SH 2008) [372]	Dermatology (1496)						8.7
New Zealand (Wallis 2014) [22]	General Practice (278)	55% >50					11.2
New Zealand (Reid 2014) [17]	General Practice (339)	71% ≥51					6.3
Thailand (Tunsuriyawong 2005) [154]	Hospital (399)	Mean 59	16.8				6.3
Singapore (Goh 1997) [18]	Dermatology outpatients (164)	Mean 49		50.0	28.0	17.0
Japan (Imafuku 2014) [359]	Dermatology (764)	Median 61		31.6	12.4	7.1
Taiwan (Tsai TF 2014) [20]	General Practice & Hospitals (150)	Mean 65				20.7
Korea (Song 2014) [25]	Specialist centres (151)	Mean 64			38.4	24.1
Japan (Kurokawa 2002) [23]	Hospitals (263)	Mean 59				26.2
Japan (Kurokawa 2007) [28]	Hospitals (316)				24.7	12.4
Korea (Cho 2014) [357]	Dermatology (305)	Mean 53			6.2
Taiwan (Jih 2009) [137]	National (34280)	33% >60		13.3	8.6
Korea (Choi 2010) [130]	Cancer screening (282)			17.7
China (Yang 2005) [355]	Dermatology (178)	NA		21.9
Korea (Herr 2002) [356]	Dermatology (188)	NA		17.0
China (Zhu 2009) [358]	Anaesthesiology (49)	Mean 65		20.4
Korea (Cheong 2014) [96]	National (11502)	100% >50	20.6
China (Song 2002) [21]	Dermatology (522)	Mean 47	6.9
		Median (range)	17.0 (2.3–50.0)				7.2 (3.2–24.1)	1.0 (0.2–52.4)	0.8 (0.8–3.0)	10.0 (1.5–61.0)		47.0 (12.2–85.0)
		Quartile range (IQR)	11.3–23.0 (11.7)				6.3–11.2 (4.9)	0.6–4.7 (4.1)	0.5–1.8 (1.3)	5.6–15.0 (9.4)		37.7–59.9 (22.3)

NS Not specified, LRT Lower respiratory tract, PHN Post-herpetic neuralgia, NA Data not available, IQR Interquartile range
^aNeurogenic bladder
^bIncident cases
^cHospitalised patients

Back to article page

ISSN: 1471-2334

Contact us

Submission enquiries: bmcinfectiousdiseases@biomedcentral.com
General enquiries: ORSupport@springernature.com